Suppose that a course of chemotherapy costs $100,000. If given to patient A, it will increase life expectancy by one month; for patient B, by six months; for patient C, by two month; for patient D, by five months; and for patient E, by four months. The marginal cost per additional year of life for the patient most likely to benefit is and the marginal cost per additional year of life for the patient least likely to benefit is $100,000; $100,000 $100,000; $1,200,000 $200,000; $100,000 O $200,000; $1,200,000

Suppose that a course of chemotherapy costs $100,000. If given to patient A, it will increase life expectancy by one month; for patient B, by six months; for patient C, by two month; for patient D, by five months; and for patient E, by four months. The marginal cost per additional year of life for the patient most likely to benefit is and the marginal cost per additional year of life for the patient least likely to benefit is $100,000; $100,000 $100,000; $1,200,000 $200,000; $100,000 O $200,000; $1,200,000

EBK HEALTH ECONOMICS AND POLICY

7th Edition

ISBN:9781337668279

Author:Henderson

Publisher:Henderson

Chapter1: U.s. Medical Care: An Uncertain Future

Section: Chapter Questions

Problem 3QAP

See similar textbooks

Similar questions

Consider two treatments. Treatment 1 saves one year of life at a cost of $10,000. Treatment 2 saves ten years of life at a cost of $1,000,000. Which treatment is more cost-effective? Why?
improvement in technology usually result in lower cost of production or new and improved consumer goods and services .Assume that an improvement in medical technolgy result in an increase in life expectancy for people 65 years and older . How would this technolgical advance be likely to affect expenditure on health care?
What does Lawson mean by a community of care (or Eudaimonic Bubble) and what does he see as being the conditions of possibility for such communities?
According to Barr, the SES into which you were born and spent your childhood has more predictive power for health as an adult than does your SES category as an adult. True False
You have been recruited as an expert in health economics to recommend what is the best therapy for a group of patients. In the image below you will find the decision tree showing the probabilities for different health states and outcomes for patients undergoing two possible treatments, No drug therapy and Drug therapy. Based on the expected cost, which therapy would you recommend as the least expensive? Explain how you arrived at your recommendation and show your calculations the space provided. No drug theraphy ? Drug theraphy ? HEALTH STATES PROBABILITIES Remain in Good Health 0.5 Develop disease A 0.2 Develop disease B 0.2 Die 0.1 Remain in Good Health 0.53 Develop disease A 0.16 Develop disease B 0.22 Die 0.09 OUTCOMES (Costs) $0 $400 $300 $200 SO $800 $500 $0
That is the "triple aim" concept as applied to health care goals?
Fabian is Canadian. His grandfather recently required chemotherapy, but was frustrated by the long delay in receiving care. Fabian recently found out that his cat will also require chemotherapy. Would Fabian expect there to be a similar delay? Explain.
For a person who previously had no insurance and received an insurance plan paying for 80 percent of all types of medical care, what increase in use would you expect for hospital care, dental care, and physician services, on average?
Sources of data for Market failure in health.
What kind of financial/societal impacts would stem cell therapy have on the healthcare system?
discuss the dominant cost components of health care.
Preventive care is not always cost-effective. Suppose that it costs $100 per person to administer a screening exam for a particular disease. Also suppose that if the screening exam finds the disease, the early detection given by the exam will avert $1,000 of costly future treatment. a. Imagine giving the screening test to 100 people. How much will it cost to give those 100 tests? Imagine a case in which 15 percent of those receiving the screening exam test positive. How much in future costly treatments will be averted? How much is saved by setting up a screening system? b. Imagine that everything is the same as in part a except that now only 5 percent of those receiving the screening exam test positive. In this case, how much in future costly treatments will be averted? How much is lost by setting up a screening system?